SPONSOR
National University Hospital, Singapore
Total Trials
6
Recruiting
6
Phases
Phase 2
Conditions studied: Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM)Glioma, AstrocyticSalivary Gland CancerThyroid CancerSolid Organ MalignanciesObstructive Sleep Apnea (OSA)Mild Cognitive ImpairmentCarcinoma, HepatocellularGastric AdenocarcinomaGastroEsophageal Cancer
National University Hospital, Singapore is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM), Glioma, Astrocytic, Salivary Gland Cancer, Thyroid Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National University Hospital, Singapore
How many clinical trials has National University Hospital, Singapore sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by National University Hospital, Singapore, of which 6 are actively recruiting participants. These trials cover conditions including Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM), Glioma, Astrocytic, Salivary Gland Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National University Hospital, Singapore research focus on?
National University Hospital, Singapore clinical trials span Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM), Glioma, Astrocytic, Salivary Gland Cancer, Thyroid Cancer, Solid Organ Malignancies, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National University Hospital, Singapore clinical trial?
To participate in a National University Hospital, Singapore trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National University Hospital, Singapore trials with current recruitment status updated daily.
Clinical Trials by National University Hospital, Singapore
NCT07241221
Recruiting
Antenatal Myo-inositol Supplementation in Pre-existing Diabetes
Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM)
NCT05532397
Recruiting
Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma
Glioma, Astrocytic
NCT06923826 Phase 2
Recruiting
Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
Salivary Gland Cancer
NCT05719428 Phase 2
Recruiting
Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies
Solid Organ Malignancies
NCT06983769
Recruiting
CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial
Obstructive Sleep Apnea (OSA)
NCT06422403 Phase 2
Recruiting
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
Carcinoma, Hepatocellular
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology